Articles

Real world cost effectiveness: lessons from the MS risk sharing scheme

19th September 2014

Real world cost effectiveness: lessons from the MS risk sharing schemeLeela Barham

Real world cost effectiveness data is in high demand, but how easy is it to find and assess in practice? Leela Barham investigates the pros and cons through an examination... Read more

How can UK pay for Sovaldi? Health bonds, says pharma leader

18th September 2014

How can UK pay for Sovaldi?  Health bonds, says pharma leaderAndrew McConaghie

The problem of highly effective but high priced and 'unaffordable' medicines such as Sovaldi needs to be addressed in the UK - and could be solved by adopting creative solutions.That... Read more

Tunnah’s musings: Taking the medical congress beyond the medic

18th September 2014

Tunnah’s musings: Taking the medical congress beyond the medicPaul Tunnah

In this month's musings, Paul Tunnah explores the continued interest in medical congresses beyond the physical event and outlines how pharmaphorum is looking to facilitate sharing virtual perspectives on them... Read more

Rewarding the best in digital innovation

17th September 2014

Rewarding the best in digital innovation  Rachel Farrow

With the PM Society's annual Digital Awards set to take place next week, pharmaphorum talks to co-chair of the Society and chair of the awards, Rachel Farrow, to get the... Read more

News

Fibrogen looks to challenge leaders in IPF

21st September 2014

Fibrogen looks to challenge leaders in IPFAndrew McConaghie

Biotech company Fibrogen wants to play as part in a new era of treating idiopathic pulmonary fibrosis, a lung disease which currently kills most sufferers within five years of diagnosis.Until... Read more

Pharma cheered by Scotland's 'no' vote

19th September 2014

Pharma cheered by Scotland's 'no' voteAndrew McConaghie

The decision by Scotland's voters to remain in the United Kingdom has been welcomed by investors and businesses at home and abroad.The final referendum result which emerged in the early... Read more

GSK China guilty of bribery

19th September 2014

GSK China guilty of briberyLinda Banks

The Changsha Intermediate People's Court in Hunan Province, China, has ruled that GlaxoSmithKline China Investment Co. Ltd (GSKCI) has, according to Chinese law, offered money or property to non-government personnel... Read more

European Commission 'has limited power to tackle drug pricing'

18th September 2014

European Commission 'has limited power to tackle drug pricing'Staff reporter

A debate in the European Parliament on access to life-saving medicines has heard that while there is widespread concern about the affordability of new therapies the European Commission (EC) has... Read more

Audio & Video

Live webinar: Is pharma brand marketing …

Kantar Health webinar


While pharma observers speculate on the death of outdated drug discovery and sales models, some critical wounds to brand marketing have been... View more

Tweetchat: Managing diabetes in the real…

Atlantis Healthcare diabetes Tweetchat


Atlantis Healthcare is working with pharmaphorum to conduct a Tweetchat on the real world challenges patients face in managing... View more

Patient Opinion Leaders: Andrew Schorr

 

As a cancer survivor and passionate patient advocate, Andrew Schorr typifies the concept of a Patient Opinion Leader (POL). He is a contributor to the... View more

View the recorded webinar - The future o…

WEBINAR COVER smaller


The global pharmaceutical market passes a significant milestone in 2014: reaching one trillion US dollars in total value. IMS Health... View more

White Papers

Diabetes in France

Diabetes in FranceJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Diabetes in Germany

Diabetes in GermanyJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Connected data and the use of smartphone…

Connected data and the use of smartphone enabled apps in market researchPaul Mannu

Rapid growth in smartphone usage offers healthcare researchers a useful tool to gain better understanding of how patients and healthcare professionals actually behave on a daily basis. Inaccuracies can arise... View info

Diabetes in the UK

Diabetes in the UKJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Further News & Articles

Cubist extends superbug R&D to Europe

Recognising that antibiotic resistance is a growing public health issue worldwide, the global leader in antib... Read more

News

NICE 'office for innovation' would smooth path of new drugs

NICE has just unveiled far-reaching proposals for a 'new approach' to managing the entry of drugs onto the NHS.<... Read more

News

Gilead drug fails in pancreatic cancer

A novel cancer treatment from Gilead has failed in phase 2 trials in advanced pancreatic cancer.
<... Read more

News

Brain cancer vaccine fast-tracked for UK patients

A brain cancer immunotherapy being developed by US company Northwest Biotherapeutics is the first drug to be app... Read more

News

Pfizer investigates GDNF treatment for Parkinson’s disease

Pfizer has struck a deal with MedGenesis Therapeutix to license its glial cell line-derived neurotrophic fact... Read more

News